Faricimab

SEATTLE — Patients with age-related macular degeneration in a veteran population experienced an increase in inactive disease after treatment with faricimab, according to a poster presented here.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Daniela Ferrara, MD, PhD, FASRS, discusses AI-based machine learning models to predict the visual acuity treatment response of Vabysmo.

Longer-acting drugs have been a great addition to our armamentarium.

In this edition, PALADIN study navigates IOP-lowering surgery in DME patients, small-molecule eye drop well-tolerated as treatment for retinal vascular diseases and more.

In this expert perspective from Hawaiian Eye 2024, Rishi P. Singh, MD, discusses how the management of retinal vein occlusion will evolve over the next year.

In this expert perspective from Hawaiian Eye 2024, Ferhina S. Ali, MD, MPH, discusses expectations for how faricimab will perform in the real world for the treatment of retinal vein occlusion.

In this expert perspective from Hawaiian Eye 2024, Kent W. Small, MD, discusses important developments in the treatment of retinal vein occlusion, or RVO.

In this video, Diana Do, MD, discusses the impact of socioeconomic disparities on patients with diabetic eye diseases.

In this video, Diana Do, MD, discusses treatment options available to patients with diabetic eye diseases.

In this expert perspective from Hawaiian Eye 2024, Jordan M. Graff, MD, FACS, discusses faricimab for the treatment of retinal vein occlusion.